Key result
Patients with stable ischemic heart disease had higher IGFBP7 concentrations compared to subjects without a history of IHD.
Why the study?
To determine the associations between IGFBP7 concentrations and concentrations of TnT, NT-proBNP, and parameters of kidney function in patients with stable IHD.
Is IGFBP7 concentration associated with subclinical myocardial damage and kidney function in patients with stable ischemic heart disease?
Observational (n=154)
Is IGFBP7 concentration associated with subclinical myocardial damage and kidney function in patients with stable ischemic heart disease?
Elevated IGFBP7 levels in patients with stable ischemic heart disease are independently associated with markers of kidney function and myocardial damage.
Answers are grounded in this paper and cite their sources.
Elevated IGFBP7 may mark subclinical damage in stable IHD; cross-sectional data leave open its clinical or prognostic utility.
The objective of this study was to determine the associations between insulin-like growth-factor-binding protein 7(IGFBP7) concentrations and concentrations of troponin T(TnT), N-terminal pro-B-type natriuretic peptide(NT-proBNP) and the parameters of kidney function in patients with stable ischemic heart disease(IHD). The IHD group consisted of 88 patients, and the population group comprised 66 subjects without a history of IHD. IGFBP7, TnT and NTproBNP concentrations were measured. The IGFBP7 value was considerably higher in the IHD group (1.76 ± 1 ng/mL vs. 1.43 ± 0.44 ng/mL, respectively, p = 0.019). Additionally, IHD subjects had a significantly higher concentration of TnT and NTproBNP. In both groups there was a significant correlation between IGFBP7 and serum parameters of kidney function (creatinine concentration: population gr. r = 0.45, p < 0.001, IHD gr. r = 0.86, p < 0.0001; urea concentration: population gr. r = 0.51, p < 0.0001, IHD gr. r = 0.71, p < 0.00001). No correlation between IGFBP7 and microalbuminuria or the albumin to creatinine ratio in urine was found. Moreover, there was a significant correlation between IGFBP7 concentration and markers of heart injury/overload-TnT and NT-BNP(r = 0.76, p < 0.001 and r = 0.72, p < 0.001, respectively). Multivariate regression analysis in joint both revealed that the IGFBP7 concentration is independently associated with urea, creatinine and TnT concentrations (R2 for the model 0.76). IHD patients presented significantly higher IGFBP7 concentrations than the population group. Elevated IGFBP7 levels are associated predominantly with markers of kidney function and myocardial damage or overload.
No takes yet. Share an insight, caveat, or question.
Lisowska et al. (2022) conducted an observational in Stable ischemic heart disease (n=154). Stable ischemic heart disease vs. Subjects without a history of IHD was evaluated on IGFBP7 concentration (p=0.019). Patients with stable ischemic heart disease had higher IGFBP7 concentrations compared to subjects without a history of IHD.
Synapse has enriched 10 related papers. Consider them for comparative context: